NCT05464082View on ClinicalTrials.gov

Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions
Breast Cancer Recurrent
Interventions
OTHER

Functional Precision Oncology

Patient derived models (PDMs), comprising patient derived xenografts (PDXs) and organoids (PDO and PDxO),

Trial Locations (1)

84112

RECRUITING

Huntsman Cancer Institute at University of Utah, Salt Lake City

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Utah

OTHER